- Report
- September 2026
- 236 Pages
Global
From €5276EUR$5,850USD£4,524GBP
- Report
- September 2026
- 506 Pages
Global
From €5276EUR$5,850USD£4,524GBP
- Report
- September 2026
- 354 Pages
Global
From €5276EUR$5,850USD£4,524GBP
- Report
- March 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- May 2026
- 185 Pages
Global
From €4058EUR$4,500USD£3,480GBP
- Report
- January 2026
- 185 Pages
Global
From €4058EUR$4,500USD£3,480GBP
- Report
- January 2026
- 180 Pages
Global
From €4058EUR$4,500USD£3,480GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- September 2026
- 294 Pages
Global
From €5276EUR$5,850USD£4,524GBP
- Report
- September 2026
- 278 Pages
Global
From €5276EUR$5,850USD£4,524GBP
- Report
- August 2026
- 150 Pages
Global
From €3382EUR$3,750USD£2,900GBP
- Report
- August 2026
- 150 Pages
Global
From €3382EUR$3,750USD£2,900GBP
- Report
- August 2026
- 30 Pages
Global
From €2480EUR$2,750USD£2,127GBP
- Report
- July 2026
- 336 Pages
Global
From €7206EUR$7,990USD£6,179GBP
- Report
- July 2026
- 178 Pages
Global
From €7206EUR$7,990USD£6,179GBP

The Blood Brain Barrier (BBB) is a specialized membrane that separates the brain from the rest of the body. It is composed of tightly packed cells that form a barrier to protect the brain from potentially harmful substances. The BBB is an important factor in the development of Central Nervous System (CNS) drugs, as it can limit the effectiveness of certain drugs. To overcome this, drug developers must create drugs that can cross the BBB and reach the target area in the brain. This requires a deep understanding of the BBB and its components, as well as the development of new drug delivery systems.
The BBB market is an important part of the CNS drug market, as it provides the necessary tools to develop effective drugs. Companies in this market include AbbVie, AstraZeneca, Biogen, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more